Shah M, Ali V, Lamba S, Abraham W T
Department of Internal Medicine, University of Kentucky, Lexington, KY, USA.
Rev Cardiovasc Med. 2001;2 Suppl 2:S2-6.
This article reviews the current understanding of the pathophysiology and clinical spectrum of heart failure. A cascade of hemodynamic and neurohormonal derangements result from a decrease in ventricular performance or cardiac output. Because neurohormonal activation has become a target for intervention in heart failure, the role of selected systems (sympathetic nervous, renin-angiotensin-aldosterone) and of natriuretic peptides is detailed. The spectrum (from compensated to acute decompensated) within which congestive heart failure patients present is reviewed, with special attention paid to the intermediate, transitional group of patients, who pose unique diagnostic and therapeutic challenges. Given these variable presentations, there is an obligation to tailor therapy accordingly.
本文综述了目前对心力衰竭病理生理学及临床谱的认识。心室功能或心输出量降低会引发一系列血液动力学和神经激素紊乱。由于神经激素激活已成为心力衰竭干预的靶点,因此详细阐述了特定系统(交感神经、肾素 - 血管紧张素 - 醛固酮)和利钠肽的作用。对充血性心力衰竭患者出现的临床谱(从代偿期到急性失代偿期)进行了综述,特别关注了处于中间过渡阶段的患者群体,他们带来了独特的诊断和治疗挑战。鉴于这些多样的临床表现,有必要相应地调整治疗方案。